The Central Mound Pedicle: A Safe and Effective Technique for Reduction Mammaplasty.

Plastic and reconstructive surgery 2020 Vol.146(4) p. 725-733

DeLong MR, Chang I, Farajzadeh M, Nahabet EH, Roostaeian J, Festekjian J, Rough J, Da Lio AL

관련 도메인

Abstract

[BACKGROUND] The central mound technique offers a relatively less common approach for breast reduction. This study evaluated the expected safety and efficacy outcomes using this technique in a large patient series.

[METHODS] A retrospective review of all patients undergoing central mound breast reduction at the authors' institution between June of 1999 and November of 2018 was performed. Both bilateral macromastia and unilateral symmetrizing reduction patients were included but evaluated separately for some outcomes. Patient demographics and comorbidities, operative details, postoperative adverse events, and BREAST-Q scores were recorded. Associations between preoperative variables and outcomes were assessed with chi-square tests, Wilcoxon tests, and Kendall tau-b correlations.

[RESULTS] A total of 325 patients were identified for inclusion (227 bilateral and 98 unilateral; 552 breasts). The average patient age was 46 years, and the average body mass index was 27.4 kg/m. Among the bilateral macromastia patients, the average operative time was 3 hours 34 minutes, and average breast tissue removed was 533 g (right breast) and 560 g (left breast). Among all patients, average follow-up was 169 days. On a per-breast basis for all patients, the following complication rates were observed: seroma, 0.2 percent; hematoma, 1.1 percent; dehiscence, 2.9 percent; infection, 1.5 percent; hypertrophic scar, 4.6 percent; nipple necrosis, 0.4 percent; fat necrosis, 0.9 percent; and skin flap necrosis, 1.7 percent. Using the BREAST-Q Reduction/Mastopexy questions on a Likert scale ranging from 1 to 5, restricted to the bilateral macromastia patient population, all scores improved with statistical significance.

[CONCLUSION] The central mound pedicle is a safe and effective approach for reduction mammaplasty for both bilateral macromastia patients and unilateral symmetrizing operations.

[CLINICAL QUESTION/LEVEL OF EVIDENCE] Therapeutic, IV.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 8
시술 mammaplasty 유방성형술 dict 2
시술 breast reduction 유방성형술 dict 2
합병증 necrosis 괴사 dict 2
시술 mastopexy 유방성형술 dict 1
시술 flap 피판재건술 dict 1
해부 fat scispacy 1
합병증 hematoma 혈종 dict 1
합병증 seroma 장액종 dict 1
합병증 infection 감염 dict 1
합병증 flap necrosis 괴사 dict 1
합병증 hypertrophic scar 비후성흉터 dict 1
합병증 dehiscence 상처열개 dict 1
합병증 nipple scispacy 1
약물 [BACKGROUND] The scispacy 1
약물 [RESULTS] A scispacy 1
질환 macromastia C0020565
Hypertrophy of Breast
scispacy 1
질환 postoperative adverse scispacy 1
질환 nipple necrosis scispacy 1
질환 breast tissue scispacy 1
기타 patient scispacy 1
기타 patients scispacy 1
기타 bilateral scispacy 1
기타 skin flap scispacy 1

MeSH Terms

Adult; Breast; Female; Humans; Hypertrophy; Mammaplasty; Middle Aged; Postoperative Complications; Retrospective Studies; Treatment Outcome

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문